# www.auroratherapeutics.com > AI-optimized mirror of www.auroratherapeutics.com containing 34 pages totalling 6,719 words of clean markdown content, structured data, and semantic HTML. Original source: https://www.auroratherapeutics.com/. Last updated: 2026-05-17T19:22:26.580Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [Extending Treatment](/site-root.html) (183 words) ## Articles & Blog Posts - [Platform](/platform/index.html) (298 words) - [Our Focus](/our-focus/index.html) (314 words) - [Aurora Therapeutics](/cart/index.html) (1 words) - [Extending Treatment](/home/index.html) (183 words) - [About Us](/about-us/index.html) (263 words) - [Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases](/news/aurora-therapeutics-launches-to-realize-potential-of-personalized-gene-editing-for-millions-of-patients-with-rare-diseases.html): Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases, (1,204 words) - [Associate Scientist, Bioanalytical Sciences](/open-positions/associate-scientist-bioanalytical-sciences/index.html): ASSOCIATE SCIENTIST, BIOANALYTICAL SCIENCES ABOUT THE COMPANY Aurora Therapeutics is transforming the development and approval of personalized gene-editing therapies for patients with rare diseases. The company utilizes advanced CRISPR technologies alongside innovative regulatory and manufactur, (498 words) - [Bioinformatics Analyst](/open-positions/bioinformatics-analyst/index.html): BIOINFORMATICS ANALYST ABOUT THE COMPANY Aurora Therapeutics is transforming the development and approval of personalized gene-editing therapies for patients with rare diseases. The company utilizes advanced CRISPR technologies alongside innovative regulatory and manufacturing frameworks to stre, (452 words) - [Fyodor Urnov, Ph.D.](/team-bios/fyodor-urnov/index.html): Professor of Molecular Therapeutics at University of California, Berkeley; Scientific Director of the Innovative Genomics Institute, Professor of Molecular Therapeutics at University of California, Berkeley; Scientific Director of the Innovative Genomics Institute (371 words) - [Edward M Kaye, M.D.](/team-bios/edward-m-kaye-md/index.html): Chief Executive Officer, Chief Executive Officer (334 words) - [Johnny Hu, Ph.D. (Chair)](/team-bios/johnny-hu/index.html): Principal at Menlo Ventures, Principal at Menlo Ventures (250 words) - [Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye](/news/category/in-the-news/index.html) (237 words) - [Morgan Maeder, Ph.D.](/team-bios/morgan-maeder/index.html): Head of Research, Head of Research (253 words) - [Greg Yap, M.B.A.](/team-bios/greg-yap/index.html): Partner at Menlo Ventures, Partner at Menlo Ventures (286 words) - [Johnny Hu, Ph.D. (Chair)](/team-bios/category/board-of-directors/index.html) (102 words) - [Johnny Hu, Ph.D. (Chair)](/team-bios/index.html) (191 words) - [David Litvak, M.B.A.](/team-bios/david-litvak/index.html): Head of CMC and Technical Operations, Head of CMC and Technical Operations (195 words) - [Associate Scientist, Bioanalytical Sciences](/open-positions/index.html) (23 words) - [Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases](/news/index.html) (30 words) - [Edward M Kaye, M.D.](/team-bios/category/leadership/index.html) (59 words) - [Jennifer Doudna, Ph.D.](/team-bios/category/founders/index.html) (90 words) - [Jennifer Doudna, Ph.D.](/team-bios/jennifer-doudna/index.html): Li Ka Shing Chancellor’s Chair and a Professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley; Howard Hughes Medical Institute investigator; President and Chair of the board of the Innovative Genomics Institute, Li Ka Shing Chancellor’s Chair and a Professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley; Howard Hughes Medical Institute investigator; President and Chair of the board of the Innovative Genomics Institute (72 words) - [Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases](/news/category/press-release/index.html) (30 words) - [Gene editing pioneers launch first startup focused on custom CRISPR therapies](/news/gene-editing-pioneers-launch-first-startup-focused-on-custom-crispr-therapies.html): Endpoints News, Endpoints News (36 words) - [JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing](/news/jpm-2026-aurora-therapeutics-edward-kaye-on-scalable-personalized-gene-editing.html): Inside Precision Medicine, Inside Precision Medicine (64 words) - [Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments](/news/crispr-pioneer-launches-startup-to-make-tailored-gene-editing-treatments.html): Wired, Wired (55 words) - [Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines](/news/key-scientist-from-baby-kj-team-launches-startup-to-scale-personalized-crispr-medicines.html): STAT, STAT (59 words) - [Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies](/news/aurora-sets-out-to-capitalize-on-fdas-new-framework-for-bespoke-drug-therapies.html): BioPharma Dive, BioPharma Dive (53 words) - [Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.](/news/gene-editing-has-struggled-to-go-commercial-this-nobel-laureate-has-a-1-billion-plan-to-fix-that.html): Forbes, Forbes (68 words) - [Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more](/news/biotech-ceos-discuss-the-state-of-the-industry-what-is-needed-to-compete-globally-the-importance-of-having-a-patient-centric-approach-and-more.html): Biotech TV, Biotech TV (68 words) - [Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye](/news/scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye.html): Cell & Gene, Cell & Gene (43 words) - [News](/news-archive/index.html) (232 words) - [Careers](/careers/index.html) (122 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/content/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/content/robots.txt): Crawler directives